Panitumumab activity in metastatic colorectal cancer patients with ≥10% epidermal growth factor receptor levels

被引：0
作者：
Chan, E.
Neubauer, M.
Swanson, P.
Harker, W.
Burris, H.
Hecht, J.
Navale, L.
Brown, J.
Amado, R.
机构：
[1] Vanderbilt Univ Sch Med, Nashville, TN USA
[2] Kansas City Canc Ctr, Overland Pk, KS USA
[3] Hematol Oncol Associates, Port St Lucie, FL USA
[4] Utah Canc Specialists, Salt Lake City, UT USA
[5] Tennessee Oncol, Nashville, TN USA
[6] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Epidermal growth factor receptor gene expression evaluation in colorectal cancer patients
    Motalleb, G.
    Pourrahmat, E.
    Najafi, S.
    Rashki, A.
    Moghadam, Yegane A.
    Mazaheri, M.
    Jahantigh, M.
    Sabagh, K.
    Sanadgol, N.
    Najafi, S.
    Talaee, R.
    [J]. INDIAN JOURNAL OF CANCER, 2014, 51 (03) : 358 - 362
  • [42] Epidermal growth factor receptor (EGFR) in primary and metastatic colorectal carcinoma
    Gupta, M
    Varma, V
    Costonis, G
    Lawson, D
    Cohen, C
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 105A - 105A
  • [43] Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
    Vincenzo Sforza
    Erika Martinelli
    Fortunato Ciardiello
    Valentina Gambardella
    Stefania Napolitano
    Giulia Martini
    Carminia della Corte
    Claudia Cardone
    Marianna L Ferrara
    Alfonso Reginelli
    Giuseppina Liguori
    Giulio Belli
    Teresa Troiani
    [J]. World Journal of Gastroenterology, 2016, 22 (28) : 6345 - 6361
  • [44] Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
    Sforza, Vincenzo
    Martinelli, Erika
    Ciardiello, Fortunato
    Gambardella, Valentina
    Napolitano, Stefania
    Martini, Giulia
    della Corte, Carminia
    Cardone, Claudia
    Ferrara, Marianna L.
    Reginelli, Alfonso
    Liguori, Giuseppina
    Belli, Giulio
    Troiani, Teresa
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (28) : 6345 - 6361
  • [45] Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer
    Zhou, Yi
    Wu, Shuang
    Qu, Fan-Jie
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (06) : 2362 - 2379
  • [46] Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer
    Kajitani, Tatsuhiro
    Makiyama, Akitaka
    Arita, Shuji
    Shimokawa, Hozumi
    Oda, Hisanobu
    Shirakawa, Tsuyoshi
    Baba, Eishi
    Esaki, Taito
    [J]. ANTICANCER RESEARCH, 2017, 37 (11) : 6459 - 6468
  • [47] Comparison of epidermal growth factor receptor levels in neoplastic and in normal colonic mucosa of patients with colorectal cancer.
    Piazzi, G
    Paterini, P
    Ceccarelli, C
    Pantaleo, MA
    Biasco, G
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8993S - 8993S
  • [48] Panitumumab in metastatic colorectal cancer
    Hocking, Christopher M.
    Townsend, Amanda R.
    Price, Timothy J.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (07) : 781 - 793
  • [49] Panitumumab induces internalization of the epidermal growth factor receptor (EGFr)
    Foltz, IN
    King, CT
    Liang, M
    Schooley, KA
    Cerretti, DP
    Freeman, D
    Radinsky, R
    Yang, XD
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9042S - 9042S
  • [50] Epidermal growth factor receptor inhibition in metastatic anal cancer
    Rogers, Jane E.
    Ohinata, Aki
    Silva, Ninoska N.
    Mehdizadeh, Amir
    Eng, Cathy
    [J]. ANTI-CANCER DRUGS, 2016, 27 (08) : 804 - 808
12345